• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-204:分子调控及其在心血管和肾脏疾病中的作用。

miR-204: Molecular Regulation and Role in Cardiovascular and Renal Diseases.

机构信息

Department of Physiology, Center of Systems Molecular Medicine, Medical College of Wisconsin, Milwaukee.

出版信息

Hypertension. 2021 Aug;78(2):270-281. doi: 10.1161/HYPERTENSIONAHA.121.14536. Epub 2021 Jun 28.

DOI:10.1161/HYPERTENSIONAHA.121.14536
PMID:34176282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8283800/
Abstract

The field of microRNA research has evolved from studies aiming to gauge the importance of microRNAs to those focusing on understanding a subset of specific microRNAs that have emerged as potent regulators of molecular systems and pathophysiological conditions. In this article, we review the molecular features and regulation of miR-204 and the growing body of evidence for an important role of miR-204 in the regulation of cardiovascular and renal physiology and pathophysiological processes. miR-204 exhibits a highly tissue-specific expression pattern, and miR-204 abundance is regulated by several transcriptional and posttranscriptional mechanisms. Strong evidence supports a role for miR-204 in attenuating pulmonary arterial hypertension and hypertensive and diabetic renal injury while promoting hypertension and endothelial dysfunction in a wide range of model systems. miR-204 may influence these disease processes by targeting several biological pathways in a tissue-specific manner. miR-204 is dysregulated in patients with cardiovascular and renal diseases. The unequivocal functional roles and clear clinical relevance indicate that miR-204 is a high-value microRNA in cardiovascular and renal diseases.

摘要

微小 RNA 研究领域已经从旨在评估微小 RNA 重要性的研究发展到专注于理解作为分子系统和病理生理状况的有效调节剂而出现的特定微小 RNA 亚类的研究。在本文中,我们回顾了 miR-204 的分子特征和调控,以及越来越多的证据表明 miR-204 在调节心血管和肾脏生理学和病理生理过程中的重要作用。miR-204 表现出高度组织特异性的表达模式,miR-204 的丰度受几种转录和转录后机制的调节。大量证据表明,miR-204 在减轻肺动脉高压和高血压及糖尿病肾损伤方面发挥作用,同时在广泛的模型系统中促进高血压和内皮功能障碍。miR-204 可能通过以组织特异性的方式靶向几种生物学途径来影响这些疾病过程。miR-204 在心血管和肾脏疾病患者中失调。明确的功能作用和明显的临床相关性表明,miR-204 是心血管和肾脏疾病中有价值的微小 RNA。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf2/8283800/0d8782673149/nihms-1710772-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf2/8283800/2e0d15448682/nihms-1710772-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf2/8283800/60a0b978d996/nihms-1710772-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf2/8283800/4619bd4e4a83/nihms-1710772-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf2/8283800/0d8782673149/nihms-1710772-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf2/8283800/2e0d15448682/nihms-1710772-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf2/8283800/60a0b978d996/nihms-1710772-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf2/8283800/4619bd4e4a83/nihms-1710772-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdf2/8283800/0d8782673149/nihms-1710772-f0004.jpg

相似文献

1
miR-204: Molecular Regulation and Role in Cardiovascular and Renal Diseases.miR-204:分子调控及其在心血管和肾脏疾病中的作用。
Hypertension. 2021 Aug;78(2):270-281. doi: 10.1161/HYPERTENSIONAHA.121.14536. Epub 2021 Jun 28.
2
Roles of MicroRNA-122 in Cardiovascular Fibrosis and Related Diseases.miR-122 在心血管纤维化及相关疾病中的作用
Cardiovasc Toxicol. 2020 Oct;20(5):463-473. doi: 10.1007/s12012-020-09603-4. Epub 2020 Aug 27.
3
Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases.综述:微小RNA在肾脏疾病病理生理学中的新作用
Am J Physiol Renal Physiol. 2016 Jan 15;310(2):F109-18. doi: 10.1152/ajprenal.00387.2015. Epub 2015 Nov 4.
4
The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury.miR-29 家族:基因组学、细胞生物学及与肾和心血管损伤的相关性。
Physiol Genomics. 2012 Feb 27;44(4):237-44. doi: 10.1152/physiolgenomics.00141.2011. Epub 2012 Jan 3.
5
MicroRNA-21 in cardiovascular disease.miRNA-21 在心血管疾病中的作用。
J Cardiovasc Transl Res. 2010 Jun;3(3):251-5. doi: 10.1007/s12265-010-9169-7. Epub 2010 May 1.
6
MiR-222 in Cardiovascular Diseases: Physiology and Pathology.心血管疾病中的MiR-222:生理学与病理学
Biomed Res Int. 2017;2017:4962426. doi: 10.1155/2017/4962426. Epub 2017 Jan 3.
7
MicroRNA-34a: role in cancer and cardiovascular disease.miRNA-34a:在癌症和心血管疾病中的作用。
Curr Drug Targets. 2014 Apr;15(4):361-73. doi: 10.2174/1389450115666140120102935.
8
Role of miR-107 and its signaling pathways in diseases.miR-107 及其信号通路在疾病中的作用。
J Recept Signal Transduct Res. 2014 Oct;34(5):338-41. doi: 10.3109/10799893.2014.896383. Epub 2014 Mar 6.
9
Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases.靶向微小RNA-34a作为心血管疾病的一种新型治疗策略。
Front Cardiovasc Med. 2022 Jan 27;8:784044. doi: 10.3389/fcvm.2021.784044. eCollection 2021.
10
Role of microRNAs in endothelial cell pathophysiology.微小RNA在内皮细胞病理生理学中的作用。
Pol Arch Med Wewn. 2011 Oct;121(10):361-6.

引用本文的文献

1
Crosstalk between noncoding RNAs and autophagy in renal cell carcinoma: Deciphering molecular pathways and therapeutic prospects.肾细胞癌中非编码RNA与自噬之间的相互作用:解读分子途径及治疗前景
Cancer Cell Int. 2025 Sep 2;25(1):318. doi: 10.1186/s12935-025-03957-x.
2
MicroRNA-204 may predict the renal function in patients with chronic kidney disease.微小RNA-204可能预测慢性肾脏病患者的肾功能。
Medicine (Baltimore). 2025 Jan 3;104(1):e41202. doi: 10.1097/MD.0000000000041202.
3
Emerging Mechanistic Insights and Therapeutic Strategies for Pulmonary Arterial Hypertension: A Focus on Right Ventricular Dysfunction and Novel Treatment Pathways.

本文引用的文献

1
Renal metabolism and hypertension.肾脏代谢与高血压。
Nat Commun. 2021 Feb 11;12(1):963. doi: 10.1038/s41467-021-21301-5.
2
Advances in oligonucleotide drug delivery.寡核苷酸药物递送的进展。
Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11.
3
Endogenous miR-204 Protects the Kidney against Chronic Injury in Hypertension and Diabetes.内源性 miR-204 保护肾脏免受高血压和糖尿病的慢性损伤。
肺动脉高压的新兴机制见解与治疗策略:聚焦右心室功能障碍和新型治疗途径
Biomedicines. 2025 Mar 1;13(3):600. doi: 10.3390/biomedicines13030600.
4
miR-204-5p Protects Nephrin from Enzymatic Degradation in Cultured Mouse Podocytes Treated with Nephrotoxic Serum.miR-204-5p在经肾毒性血清处理的培养小鼠足细胞中保护Nephrin免受酶促降解。
Cells. 2025 Mar 1;14(5):364. doi: 10.3390/cells14050364.
5
Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies.肺动脉高压:分子机制与临床研究
MedComm (2020). 2025 Mar 10;6(3):e70134. doi: 10.1002/mco2.70134. eCollection 2025 Mar.
6
Exercise promotes peripheral glycolysis in skeletal muscle through miR-204 induction via the HIF-1α pathway.运动通过缺氧诱导因子-1α(HIF-1α)途径诱导miR-204,从而促进骨骼肌的外周糖酵解。
Sci Rep. 2025 Jan 9;15(1):1487. doi: 10.1038/s41598-025-85174-0.
7
Effects of miR-204-5p modulation on PAX6 regulation and corneal inflammation.miR-204-5p 调控对 PAX6 调控和角膜炎症的影响。
Sci Rep. 2024 Nov 2;14(1):26436. doi: 10.1038/s41598-024-76654-w.
8
Role of MicroRNA-204 in Regulating the Hallmarks of Breast Cancer: An Update.微小RNA-204在调控乳腺癌特征中的作用:最新进展
Cancers (Basel). 2024 Aug 10;16(16):2814. doi: 10.3390/cancers16162814.
9
Identification and Validation of the miR/RAS/RUNX2 Autophagy Regulatory Network in AngII-Induced Hypertensive Nephropathy in MPC5 Cells Treated with Hydrogen Sulfide Donors.硫化氢供体处理的MPC5细胞中血管紧张素II诱导的高血压肾病中miR/RAS/RUNX2自噬调节网络的鉴定与验证
Antioxidants (Basel). 2024 Aug 7;13(8):958. doi: 10.3390/antiox13080958.
10
Disturbed flow regulates protein disulfide isomerase A1 expression via microRNA-204.紊乱血流通过微小RNA-204调节蛋白质二硫键异构酶A1的表达。
Front Physiol. 2024 Apr 4;15:1327794. doi: 10.3389/fphys.2024.1327794. eCollection 2024.
J Am Soc Nephrol. 2020 Jul;31(7):1539-1554. doi: 10.1681/ASN.2019101100. Epub 2020 Jun 2.
4
TRPM3_miR-204: a complex locus for eye development and disease.TRPM3-miR-204:眼部发育和疾病的复杂基因座。
Hum Genomics. 2020 Feb 18;14(1):7. doi: 10.1186/s40246-020-00258-4.
5
miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database.miRTarBase 2020:实验验证的 microRNA-靶标相互作用数据库更新。
Nucleic Acids Res. 2020 Jan 8;48(D1):D148-D154. doi: 10.1093/nar/gkz896.
6
Long non-coding RNA KCNQ1OT1/microRNA-204-5p/LGALS3 axis regulates myocardial ischemia/reperfusion injury in mice.长链非编码 RNA KCNQ1OT1/微小 RNA-204-5p/半乳糖凝集素 3 轴调控小鼠心肌缺血/再灌注损伤。
Cell Signal. 2020 Feb;66:109441. doi: 10.1016/j.cellsig.2019.109441. Epub 2019 Oct 20.
7
Serum miR-204 is an early biomarker of type 1 diabetes-associated pancreatic beta-cell loss.血清 miR-204 是 1 型糖尿病相关胰岛β细胞损失的早期生物标志物。
Am J Physiol Endocrinol Metab. 2019 Oct 1;317(4):E723-E730. doi: 10.1152/ajpendo.00122.2019. Epub 2019 Aug 13.
8
LncRNA HIF1A-AS1 contributes to ventricular remodeling after myocardial ischemia/reperfusion injury by adsorption of microRNA-204 to regulating SOCS2 expression.长链非编码 RNA HIF1A-AS1 通过吸附 microRNA-204 来调节 SOCS2 表达,从而促进心肌缺血/再灌注损伤后的心室重构。
Cell Cycle. 2019 Oct;18(19):2465-2480. doi: 10.1080/15384101.2019.1648960. Epub 2019 Aug 5.
9
Noncoding RNAs in Hypertension.高血压中的非编码RNA
Hypertension. 2019 Sep;74(3):477-492. doi: 10.1161/HYPERTENSIONAHA.119.13412. Epub 2019 Jul 29.
10
Regulation of phagolysosomal activity by miR-204 critically influences structure and function of retinal pigment epithelium/retina.miR-204 通过调控吞噬溶酶体活性对视网膜色素上皮/视网膜的结构和功能有重要影响。
Hum Mol Genet. 2019 Oct 15;28(20):3355-3368. doi: 10.1093/hmg/ddz171.